Cerebral Gigantism |
|
|
Clinical Trial: Predictive Value of Dynamic Contrast Enhancement MRI on a Cerebral Tumor Response to Gamma Knife Treatment.
This study is currently recruiting patients.
Verified by Universitaire de Sherbrooke September 2005
|
Purpose
Hypothesis: the pattern of perfusion at the MRI after gadolinium injection is different in tumors that respond well to gamma knife.
We are going to acquier perfusion images of brain lesion before and after a treatment with gamma knife to look if we can predict wich of the tumor will best respond to the treatment. We are also going to study the change in the enhancement pattern after a gamma knife treatment.
| Condition |
|---|
| cerebral metastases |
MedlinePlus related topics: Brain Cancer
Study Type: Observational
Study Design: Screening, Longitudinal, Defined Population, Prospective Study
Official Title: Prospective Study of Predictive Value of Dynamic Contrast Enhancement Magnetic Resonance Imaging with Gadolinium on the Response of a Cerebral Tumor to a Treatment with Gamma Knife.
Expected Total Enrollment: 30
Study start: August 2005
Eligibility
Inclusion Criteria:
- Patient with intracerebral lesion benign or malignant wich are not concerned by the exclusion criteria
Exclusion Criteria:
- Pancranial radiotherapy
- Residual postop lesion
- Gliomas
- Patients < 18 years old
- Anterior allergic reaction to gadolinium
- Claustrophobia.
Location and Contact Information
Canada, Quebec
Faculté de médecine, Université de Sherbrooke, Fleurimont, Quebec, J1H 5N4, Canada; Recruiting
Martin Lepage, PhD 1-819-346-1110 Ext. 12820
Chenard Jean, MD, Principal Investigator
Jean Chenard, MD, Principal Investigator, University of Sherbrooke
More Information
Last Updated: September 9, 2005
Record first received: September 7, 2005
ClinicalTrials.gov Identifier: NCT00156585
Health Authority: Canada: Health Canada
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Cerebral Gigantism (National Institute of Neurological Disorders and Stroke)

Not Signed In -

